Massive posttraumatic bleeding: Epidemiology, causes, clinical features, and therapeutic management

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 1, 2013, Pages 83-93

  Lippi, Giuseppe ^a   Favaloro, Emmanuel J ^b   Cervellin, Gianfranco ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

bleeding; hemorrhages; recombinant activated factor VIII; trauma

Indexed keywords

HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLEEDING; ERYTHROCYTE CONCENTRATE; FLUID RESUSCITATION; HEMOSTASIS; HUMAN; MORTALITY; PATIENT SAFETY; PH; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOEMBOLISM;

AMPUTATION; BLOOD TRANSFUSION; FACTOR VIIA; FRACTURES, BONE; HEMORRHAGE; HUMANS; PLASMA; RECOMBINANT PROTEINS; WOUNDS AND INJURIES; WOUNDS, PENETRATING;

EID: 84873407974     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1328936     Document Type: Article

References (115)

1. Gutierrez G., Reines H. D., Wulf-Gutierrez M. E. Clinical review: hemorrhagic shock. Crit Care: 2004; 8 5 373 381
2. Marietta M., Pedrazzi P., Girardis M., Busani S., Torelli G. Posttraumatic massive bleeding: a challenging multidisciplinary task. Intern Emerg Med: 2010; 5 6 521 531
3. Bourke D. L., Smith T. C. Estimating allowable hemodilution. Anesthesiology: 1974; 41 6 609 612
4. Lippi G., Franchini M., Guidi G. C. Diagnostic approach to inherited bleeding disorders. Clin Chem Lab Med: 2007; 45 1 2 12
5. Jayandharan G. R., Srivastava A., Srivastava A. Role of molecular genetics in hemophilia: from diagnosis to therapy. Semin Thromb Hemost: 2012; 38 1 64 78
6. Franchini M., Lippi G. Acquired factor VIII inhibitors. Blood: 2008; 112 2 250 255
7. Favaloro E. J. Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder. Semin Thromb Hemost: 2011; 37 5 440 455
8. Lippi G., Franchini M., Montagnana M., Favaloro E. J. Inherited disorders of blood coagulation. Ann Med: 2012; 44 5 405 418
9. Hayward C. P., Bunimov N. Thrombocytopenic platelet disorders. Semin Thromb Hemost: 2011; 37 6 617 620
10. Favaloro E. J., Lippi G., Franchini M. Contemporary platelet function testing. Clin Chem Lab Med: 2010; 48 5 579 598
11. Tufano A., Coppola A., Cerbone A. M., Ruosi C., Franchini M. Preventing postsurgical venous thromboembolism: pharmacological approaches. Semin Thromb Hemost: 2011; 37 3 252 266
12. Linden M. D., Tran H., Woods R., Tonkin A. High platelet reactivity and antiplatelet therapy resistance. Semin Thromb Hemost: 2012; 38 2 200 212
13. Curry N., Hopewell S., Dorée C., Hyde C., Brohi K., Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care: 2011; 15 2 R92
14. Kauvar D. S., Wade C. E. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care: 2005; 9 05 S1 S9
15. Levi M. Disseminated intravascular coagulation: a disease-specific approach. Semin Thromb Hemost: 2010; 36 4 363 365
16. Kauvar D. S., Lefering R., Wade C. E. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma: 2006; 60 6 (Suppl) S3 S11
17. Society of Critical Care Medicine, Chinese Medical Association [Guidelines for resuscitation of hypovolemic shock (2007)]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue: 2008; 20 3 129 134
18. Gutierrez G., Reines H. D., Wulf-Gutierrez M. E. Clinical review: hemorrhagic shock. Crit Care: 2004; 8 5 373 381
19. Gutierrez G., Marini C., Acero A. L., Lund N. Skeletal muscle PO2 during hypoxemia and isovolemic anemia. J Appl Physiol: 1990; 68 5 2047 2053
20. Gaarder C., Naess P. A., Frischknecht Christensen E., et al. Scandinavian Guidelines-"The massively bleeding patiento" Scand J Surg: 2008; 97 1 15 36
21. Lippi G., Cervellin G. Disseminated intravascular coagulation in trauma injuries. Semin Thromb Hemost: 2010; 36 4 378 387
22. Lee J. M., Grabb M. C., Zipfel G. J., Choi D. W. Brain tissue responses to ischemia. J Clin Invest: 2000; 106 6 723 731
23. Blaisdell F. W. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg: 2002; 10 6 620 630
24. Reimer K. A., Jennings R. B. Energy metabolism in the reversible and irreversible phases of severe myocardial ischemia. Acta Med Scand Suppl: 1981; 651 19 27
25. Ereciska M., Silver I. A. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol: 2001; 128 3 263 276
26. Derikx J. P., Matthijsen R. A., de Bruïne A. P., et al. Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS ONE: 2008; 3 10 e3428
27. Huguet C., Gavelli A., Bona S. Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg: 1994; 178 5 454 458
28. Kheirbek T., Kochanek A. R., Alam H. B. Hypothermia in bleeding trauma: a friend or a foe? Scand J Trauma Resusc Emerg Med: 2009; 17 65
29. Cairns C. B. Rude unhinging of the machinery of life: metabolic approaches to hemorrhagic shock. Curr Opin Crit Care: 2001; 7 6 437 443
30. Lippi G., Banfi G. Exercise-related increase of cardiac troponin release in sports: An apparent paradox finally elucidated? Clin Chim Acta: 2010; 411 7-8 610 611
31. Hierholzer C., Billiar T. R. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg: 2001; 386 4 302 308
32. Sethi A. K., Sharma P., Mohta M., Tyagi A. Shock-a short review. Indian J Anaesth: 2003; 47 5 345 359
33. Dutton R. P. Current concepts in hemorrhagic shock. Anesthesiol Clin: 2007; 25 1 23 34, viii
34. Molitoris B. A., Sutton T. A. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int: 2004; 66 2 496 499
35. Cervellin G., Comelli I., Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med: 2010; 48 6 749 756
36. Gross S. A System of Surgery: Pathological, Diagnostic, Therapeutic, and Operative. Philadelphia, PA Henry C. Lea: 1862
37. Hinshaw L. B., Cox B. G. The Fundamental Mechanisms of Shock. New York, NY Plenum Press: 1862
38. Kauvar D. S., Lefering R., Wade C. E. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma: 2006; 60 6, Suppl S3 S11
39. Sharma O. P., Hagler S., Oswanski M. F. Prevalence of delayed hemothorax in blunt thoracic trauma. Am Surg: 2005; 71 6 481 486
40. Dente C. J., Ustin J., Feliciano D. V., et al. The accuracy of thoracic ultrasound for detection of pneumothorax is not sustained over time: a preliminary study. J Trauma: 2007; 62 6 1384 1389
41. Cohen R., Woods H. Clinical and Biochemical Aspects of Lactic Acidosis. Boston, MA Blackwell Scientific Publications: 1976
42. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care: 2006; 12 4 315 321
43. Gunnerson K. J., Saul M., He S., Kellum J. A. Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit Care: 2006; 10 1 R22
44. Lippi G., Montagnana M., Targher G. Higher random plasma glucose level is associated with increased plasma cardiac troponin in emergency department patients with suspected acute coronary syndrome. Am J Cardiol: 2012; 109 5 775 776
45. Ceriotti F., Henny J., Queraltó J., et al. IFCC Committee on Reference Intervals and Decision Limits (C-RIDL); Committee on Reference Systems for Enzymes (C-RSE) Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study. Clin Chem Lab Med: 2010; 48 11 1593 1601
46. Lippi G., Valentino M., Cervellin G. Laboratory diagnosis of acute pancreatitis: in search of the Holy Grail. Crit Rev Clin Lab Sci: 2012; 49 1 18 31
47. Lippi G., Cervellin G. Degradation of troponin I in serum or plasma: mechanisms, and analytical and clinical implications. Semin Thromb Hemost: 2012; 38 2 222 229
48. Lippi G., Plebani M. Neutrophil gelatinase-associated lipocalin (NGAL): the laboratory perspective. Clin Chem Lab Med: 2012; 50 9 1483 1487
49. Cervellin G., di Somma S. Neutrophil gelatinase-associated lipocalin (NGAL): the clinician's perspective. Clin Chem Lab Med: 2012; 50 9 1489 1493
50. Lippi G., Meschi T., Cervellin G. Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: clinical evidence and perspectives. Eur J Intern Med: 2011; 22 5 460 465
51. Favaloro E. J. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost: 2010; 36 4 458 467
52. Ranucci M., Baryshnikova E., Colella D. Monitoring prohemostatic treatment in bleeding patients. Semin Thromb Hemost: 2012; 38 3 282 291
53. Cervellin G., Benatti M., Carbucicchio A., et al. Serum levels of protein S100B predict intracranial lesions in mild head injury. Clin Biochem: 2012; 45 6 408 411
54. Lippi G., Aloe R., Numeroso F., Cervellin G. The significance of protein S-100B testing in cardiac arrest patients. Clin Biochem: 2011; 44 8-9 567 575
55. Shapiro M. B., Jenkins D. H., Schwab C. W., Rotondo M. F. Damage control: collective review. J Trauma: 2000; 49 5 969 978
56. Rossaint R., Bouillon B., Cerny V., et al. Task Force for Advanced Bleeding Care in Trauma Management of bleeding following major trauma: an updated European guideline. Crit Care: 2010; 14 2 R52
57. Committee on Fluid Resuscitation for Combat Casualties Fluid Resuscitation: State of the Science for Treating Combat Casualties and Civilian Trauma (Report of the Institute of Medicine). Washington, DC National Academies Press: 1999
58. Bickell W. H., Wall M. J. Jr, Pepe P. E., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med: 1994; 331 17 1105 1109
59. Cotton B. A., Guy J. S., Morris J. A. Jr, Abumrad N. N. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock: 2006; 26 2 115 121
60. Mapstone J., Roberts I., Evans P. Fluid resuscitation strategies: a systematic review of animal trials. J Trauma: 2003; 55 3 571 589
61. Morrison C. A., Carrick M. M., Norman M. A., et al. Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: preliminary results of a randomized controlled trial. J Trauma: 2011; 70 3 652 663
62. Dutton R. P., Mackenzie C. F., Scalea T. M. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma: 2002; 52 6 1141 1146
63. Tieu B. H., Holcomb J. B., Schreiber M. A. Coagulopathy: its pathophysiology and treatment in the injured patient. World J Surg: 2007; 31 5 1055 1064
64. Cannon W., Frawer J., Cowell E. The preventive treatment of wound shock. JAMA: 1918; 70 618 621
65. NATO Emergency War Surgery. Third United States revision of the emergency war surgery NATO Handbook. Washington DC US Department of Defense: 2004
66. Holcomb J. B. Fluid resuscitation in modern combat casualty care: lessons learned from Somalia. J Trauma: 2003; 54 5, Suppl S46 S51
67. Rotondo M. F., Zonies D. H. The damage control sequence and underlying logic. Surg Clin North Am: 1997; 77 4 761 777
68. Alam H. B., Bice L. M., Butt M. U., et al. Hemostatic Resuscitation Research Group Testing of blood products in a polytrauma model: results of a multi-institutional randomized preclinical trial. J Trauma: 2009; 67 4 856 864
69. McSwain N. E., Champion H. R., Fabian T. C., et al. State of the art of fluid resuscitation 2010: prehospital and immediate transition to the hospital. J Trauma: 2011; 70 5, Suppl S2 S10
70. Chiara O., Bucci L., Sara A., Bassi G., Vesconi S. Quality and quantity of volume replacement in trauma patients. Minerva Anestesiol: 2008; 74 6 303 306
71. Kiraly L. N., Differding J. A., Enomoto T. M., et al. Resuscitation with normal saline (NS) vs. lactated ringers (LR) modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemorrhagic shock swine model. J Trauma: 2006; 61 1 57 64, discussion 64-65
72. Finfer S., Bellomo R., Boyce N., French J., Myburgh J., Norton R.; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med: 2004; 350 22 2247 2256
73. Ogilvie M. P., Pereira B. MT, McKenney M. G., et al. First report on safety and efficacy of hetastarch solution for initial fluid resuscitation at a level 1 trauma center. J Am Coll Surg: 2010; 210 5 870 880, 880-882
74. Perner A., Haase N., Guttormsen A. B., et al. 6S Trial Group; Scandinavian Critical Care Trials Group Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med: 2012; 367 2 124 134
75. Gross D., Landau E. H., Klin B., Krausz M. M. Quantitative measurement of bleeding following hypertonic saline therapy in 'uncontrolled' hemorrhagic shock. J Trauma: 1989; 29 1 79 83
76. Krausz M. M., Landau E. H., Klin B., Gross D. Hypertonic saline treatment of uncontrolled hemorrhagic shock at different periods from bleeding. Arch Surg: 1992; 127 1 93 96
77. Kauvar D. S., Holcomb J. B., Norris G. C., Hess J. R. Fresh whole blood transfusion: a controversial military practice. J Trauma: 2006; 61 1 181 184
78. Bombeli T., Spahn D. R. Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage. Br J Anaesth: 2004; 93 2 275 287
79. Valeri C. R., Cassidy G., Pivacek L. E., et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion: 2001; 41 8 977 983
80. Ciesla D. J., Moore E. E., Johnson J. L., Burch J. M., Cothren C. C., Sauaia A. A 12-year prospective study of postinjury multiple organ failure: has anything changed? Arch Surg: 2005; 140 5 432 438, discussion 438-440
81. Dewar D. C., Butcher N. E., King K. L., Balogh Z. J. Post injury multiple organ failure. Trauma: 2011; 13 81 91
82. Napolitano L. Cumulative risks of early red blood cell transfusion. J Trauma: 2006; 60 6, Suppl S26 S34
83. Offner P. J., Moore E. E., Biffl W. L., Johnson J. L., Silliman C. C. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg: 2002; 137 6 711 716, discussion 716-717
84. Friese R. S., Sperry J. L., Phelan H. A., Gentilello L. M. The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients. Am J Surg: 2008; 196 1 56 61
85. Nathens A. B., Nester T. A., Rubenfeld G. D., Nirula R., Gernsheimer T. B. The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock: 2006; 26 4 342 347
86. Lier H., Krep H., Schroeder S., Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma: 2008; 65 4 951 960
87. Vivien B., Langeron O., Morell E., et al. Early hypocalcemia in severe trauma. Crit Care Med: 2005; 33 9 1946 1952
88. Lozano M. L., Rivera J., Gónzález-Conejero R., Moraleda J. M., Vicente V. Loss of high-affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin. Transfusion: 1997; 37 4 368 375
89. Shakur H., Roberts I., Bautista R., et al. CRASH-2 trial collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet: 2010; 376 9734 23 32
90. Roberts I., Shakur H., Afolabi A., et al. CRASH-2 collaborators The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet: 2011; 377 9771 1096 1101, 1101, e1-e2
91. Paran H., Gutman M., Mayo A. The effect of aprotinin in a model of uncontrolled hemorrhagic shock. Am J Surg: 2005; 190 3 463 466
92. Levy J. H. Antifibrinolytic therapy: new data and new concepts. Lancet: 2010; 376 9734 3 4
93. Bolliger D., Görlinger K., Tanaka K. A. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology: 2010; 113 5 1205 1219
94. Hirshberg A., Dugas M., Banez E. I., Scott B. G., Wall M. J. Jr, Mattox K. L. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma: 2003; 54 3 454 463
95. Gonzalez E. A., Moore F. A., Holcomb J. B., et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma: 2007; 62 1 112 119
96. Davenport R., Curry N., Manson J., et al. Hemostatic effects of fresh frozen plasma may be maximal at red cell ratios of 1:2. J Trauma: 2011; 70 1 90 95, discussion 95-96
97. Stinger H. K., Spinella P. C., Perkins J. G., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma: 2008; 64 2 (Suppl) S79 S85, discussion S85
98. MacLennan S., Williamson L. M. Risks of fresh frozen plasma and platelets. J Trauma: 2006; 60 6 (Suppl) S46 S50
99. O'Shaughnessy D. F., Atterbury C., Bolton Maggs P., et al. British Committee for Standards in Haematology, Blood Transfusion Task Force Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol: 2004; 126 1 11 28
100. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology: 1996; 84 3 732 747
101. Lippi G., Favaloro E. J. Recombinants in thrombosis and hemostasis: from basic research to clinical therapy. Semin Thromb Hemost: 2010; 36 5 471 476
102. Franchini M., Montagnana M., Targher G., Zaffanello M., Lippi G. The use of recombinant factor VIIa in liver diseases. Blood Coagul Fibrinolysis: 2008; 19 5 341 348
103. Franchini M., Franchi M., Bergamini V., et al. The use of recombinant activated FVII in postpartum hemorrhage. Clin Obstet Gynecol: 2010; 53 1 219 227
104. Franchini M., Targher G., Lippi G. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med: 2011; 364 6 575, author reply 575-576
105. Franchini M., Lippi G. Recombinant activated factor VII: mechanisms of action and current indications. Semin Thromb Hemost: 2010; 36 5 485 492
106. Dutton R. P., McCunn M., Hyder M., et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma: 2004; 57 4 709 718, discussion 718-719
107. Boffard K. D., Riou B., Warren B., et al. NovoSeven Trauma Study Group Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma: 2005; 59 1 8 15, discussion 15-18
108. Dutton R. P., Parr M., Tortella B. J., et al. CONTROL Study Group Recombinant activated factor VII safety in trauma patients: results from the CONTROL trial. J Trauma: 2011; 71 1 12 19
109. Wafaisade A., Lefering R., Maegele M., et al. TraumaRegister der Deutschen Gesellschaft für Unfallchirurgie Recombinant factor VIIa for the treatment of exsanguinating trauma patients: a matched-pair analysis from the Trauma Registry of the German Society for Trauma Surgery. Unfallchirurg: 2012; (e-pub ahead of print). DOI: 10.1007/s00113-011-2146-z
110. Morel N., Chabarttier C., Merson L., et al. Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience. J Emerg Trauma Shock: 2012; 5 2 143 148
111. Koh Y. R., Cho S. J., Yeom S. R., et al. Evaluation of recombinant factor VIIa treatment for massive hemorrhage in patients with multiple traumas. Ann Lab Med: 2012; 32 2 145 152
112. Simpson E., Lin Y., Stanworth S., Birchall J., Doree C., Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev: 2012; 3 CD005011
113. Shibeko A. M., Woodle S. A., Lee T. K., Ovanesov M. V. Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids. Blood: 2012; 120 4 891 899
114. Tobin J. M., Varon A. J. Update in trauma anesthesiology: perioperative resuscitation management. Anesth Analg: 2012; (e-pub ahead of print). 10.1213/ANE.0b013e3182639f20
115. Davidson G. H., Hamlat C. A., Rivara F. P., Koepsell T. D., Jurkovich G. J., Arbabi S. Long-term survival of adult trauma patients. JAMA: 2011; 305 10 1001 1007